XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2018   10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 $ 132,460 $ (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 18,839   18,839  
Net unrealized gain on securities available for sale, net of tax 8,737     8,737
Net unrealized loss on cash flow hedging derivative instruments, net of tax (1,703)     (1,703)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 8     8
Comprehensive income (loss) 25,881   18,839 7,042
Cash dividends declared (9,694)   (9,694)  
Equity compensation expense 368 $ 368    
Payment to repurchase common stock (in shares)   (4,179)    
Payment to repurchase common stock (96)   (96)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   18,772    
Proceeds from sale of common stock $ 488 $ 488    
Ending balance (in shares) at Sep. 30, 2019 10,896,331 10,896,331    
Ending balance at Sep. 30, 2019 $ 208,489 $ 63,711 141,509 3,269
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends declared (usd per share) $ 0.89      
     Net income $ 6,288      
Net unrealized gain on securities available for sale, net of tax 936      
Net unrealized loss on cash flow hedging derivative instruments, net of tax (340)      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 1      
Ending balance (in shares) at Sep. 30, 2019 10,896,331 10,896,331    
Ending balance at Sep. 30, 2019 $ 208,489 $ 63,711 141,509 3,269
Beginning balance (in shares) at Dec. 31, 2019 10,899,210 10,899,210    
Beginning balance at Dec. 31, 2019 $ 212,508 $ 64,073 144,839 3,596
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
     Net income 20,159   20,159  
Net unrealized gain on securities available for sale, net of tax 1,863     1,863
Net unrealized loss on cash flow hedging derivative instruments, net of tax (5,897)     (5,897)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 43     43
Comprehensive income (loss) 16,168   20,159 (3,991)
Cash dividends declared (10,058)   (10,058)  
Equity compensation expense 482 $ 482    
Payment to repurchase common stock (in shares)   (5,447)    
Payment to repurchase common stock (157)   (157)  
Issuance of restricted stock (in shares)   27,345    
Proceeds from sale of common stock (in shares)   21,851    
Proceeds from sale of common stock $ 497 $ 497    
Ending balance (in shares) at Sep. 30, 2020 10,942,959 10,942,959    
Ending balance at Sep. 30, 2020 $ 219,440 $ 65,052 154,783 (395)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Cash dividends declared (usd per share) $ 0.92      
     Net income $ 7,095      
Net unrealized gain on securities available for sale, net of tax (1,580)      
Net unrealized loss on cash flow hedging derivative instruments, net of tax 387      
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax $ 7      
Ending balance (in shares) at Sep. 30, 2020 10,942,959 10,942,959    
Ending balance at Sep. 30, 2020 $ 219,440 $ 65,052 $ 154,783 $ (395)